Literature DB >> 19364982

Low-density lipoprotein cholesterol concentrations and death due to intraparenchymal hemorrhage: the Ibaraki Prefectural Health Study.

Hiroyuki Noda1, Hiroyasu Iso, Fujiko Irie, Toshimi Sairenchi, Emiko Ohtaka, Mikio Doi, Yoko Izumi, Hitoshi Ohta.   

Abstract

BACKGROUND: Few studies have examined the association between low levels of low-density lipoprotein (LDL) cholesterol and risk of intraparenchymal hemorrhage. METHODS AND
RESULTS: A total of 30 802 men and 60 417 women, 40 to 79 years of age with no history of stroke or coronary heart disease, completed a baseline risk factor survey in 1993 under the auspices of the Ibaraki Prefectural Health Study. Systematic mortality surveillance was performed through 2003, and 264 intraparenchymal hemorrhage deaths were identified. LDL cholesterol levels were calculated with the Friedewald formula. Persons with LDL cholesterol > or =140 mg/dL had half the sex- and age-adjusted risk of death due to intraparenchymal hemorrhage of those with LDL cholesterol <80 mg/dL. After adjustment for cardiovascular risk factors, the multivariable hazard ratio compared with persons with LDL cholesterol <80 mg/dL was 0.65 (95% CI 0.44 to 0.96) for those with LDL cholesterol 80 to 99 mg/dL, 0.48 (0.32 to 0.71) for 100 to 119 mg/dL, 0.50 (0.33 to 0.75) for 120 to 139 mg/dL, and 0.45 (0.30 to 0.69) for >/=140 mg/dL. These inverse associations were not altered substantially after the exclusion of persons with hypertriglyceridemia, after analysis with a Cox proportional hazard model with time-dependent covariates, or in sensitivity analysis for the potential effect of competing risks.
CONCLUSIONS: Low LDL cholesterol levels are associated with elevated risk of death due to intraparenchymal hemorrhage.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19364982     DOI: 10.1161/CIRCULATIONAHA.108.795666

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  44 in total

1.  Subacute decline in serum lipids precedes the occurrence of primary intracerebral hemorrhage.

Authors:  Chia-Ling Phuah; Miriam R Raffeld; Alison M Ayres; Anand Viswanathan; Steven M Greenberg; Alessandro Biffi; Jonathan Rosand; Christopher D Anderson
Journal:  Neurology       Date:  2016-04-29       Impact factor: 9.910

2.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

3.  Low-Density Lipoprotein Cholesterol and Risk of Hemorrhagic Stroke: a Systematic Review and Dose-Response Meta-analysis of Prospective Studies.

Authors:  Chaoran Ma; Muzi Na; Samantha Neumann; Xiang Gao
Journal:  Curr Atheroscler Rep       Date:  2019-11-20       Impact factor: 5.113

4.  The Influence of Diffusion Weighted Imaging Lesions on Outcomes in Patients with Acute Spontaneous Intracerebral Hemorrhage.

Authors:  Rajeev K Garg; Jawad Khan; Robert J Dawe; James Conners; Sayona John; Shyam Prabhakaran; Mehmet Kocak; Sudeep Bhabad; Sean L Simpson; Bichun Ouyang; Miral Jhaveri; Thomas P Bleck
Journal:  Neurocrit Care       Date:  2020-10       Impact factor: 3.210

5.  BMI modifies the association between serum HDL cholesterol and stroke in a hypertensive population without atrial fibrillation.

Authors:  Y Yu; L Hu; X Huang; W Zhou; H Bao; X Cheng
Journal:  J Endocrinol Invest       Date:  2020-05-13       Impact factor: 4.256

6.  Inverse association of plasma level of high-density lipoprotein cholesterol with intracerebral hemorrhage.

Authors:  Xinguo Wang; Shaohua Li; Yongyi Bai; Xiaohan Fan; Kai Sun; Jizheng Wang; Rutai Hui
Journal:  J Lipid Res       Date:  2011-06-16       Impact factor: 5.922

7.  Treatment of risk factors to prevent stroke.

Authors:  Junya Aoki; Ken Uchino
Journal:  Neurotherapeutics       Date:  2011-07       Impact factor: 7.620

8.  Severe underweight and cerebral microbleeds.

Authors:  Shigeki Yamada; Takeshi Satow; Atsushi Fukuda; Miki Ito; Masaaki Saiki
Journal:  J Neurol       Date:  2012-06-19       Impact factor: 4.849

Review 9.  LDL cholesterol goals in high-risk patients: how low do we go and how do we get there?

Authors:  Joost Besseling; Julian van Capelleveen; John J P Kastelein; G Kees Hovingh
Journal:  Drugs       Date:  2013-03       Impact factor: 9.546

Review 10.  Safety of statins: an update.

Authors:  Miao Hu; Bernard M Y Cheung; Brian Tomlinson
Journal:  Ther Adv Drug Saf       Date:  2012-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.